PT Prodia Widyahusada TbkPRWDF 76 Forward PE Ratio is 11.54 as of Jul. 01, 2026. GuruFocus rates PRWDF with a GF Score™ of 76/100. The stock has 2 warning signs investors should review. Among 87 Medical Diagnostics & Research companies, PT Prodia Widyahusada Tbk ranks better than 90.8% on this metric.
PT Prodia Widyahusada Tbk (OTCPK:PRWDF) Forward PE Ratio Explanation
The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.
Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .
PT Prodia Widyahusada Tbk Forward PE Ratio Related Terms
PT Prodia Widyahusada Tbk Forward PE Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Prodia Widyahusada Tbk Forward PE Ratio Chart
PT Prodia Widyahusada Tbk Annual Data
Trend
Forward PE Ratio
PT Prodia Widyahusada Tbk Quarterly Data
Forward PE Ratio
PRWDF vs TMO, DHR, IDXX: Forward PE Ratio Comparison
For the Diagnostics & Research subindustry, PT Prodia Widyahusada Tbk's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Prodia Widyahusada Tbk Forward PE Ratio vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, PT Prodia Widyahusada Tbk's Forward PE Ratio distribution charts can be found below:
* The bar in red indicates where PT Prodia Widyahusada Tbk's Forward PE Ratio falls into.
PT Prodia Widyahusada Tbk Forward PE Ratio Calculation
It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.
PT Prodia Widyahusada Tbk (PRWDF) has a Forward PE Ratio of 11.54 as of Jul. 01, 2026. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on PT Prodia Widyahusada Tbk and its competitors. According to the industry distribution chart, PT Prodia Widyahusada Tbk ranks #8 out of 87 companies in the Medical Diagnostics & Research industry, placing it in the top 9.2%.
Is PT Prodia Widyahusada Tbk's Forward PE Ratio too high?
PT Prodia Widyahusada Tbk's current Forward PE Ratio is 11.54. The Medical Diagnostics & Research industry median Forward PE Ratio is 21.92. PT Prodia Widyahusada Tbk's value of 11.54 is 47.4% below this industry median. Based on the distribution chart, PT Prodia Widyahusada Tbk ranks #8 out of 87 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, PT Prodia Widyahusada Tbk has a GF Score™ of 76/100, reflecting its overall financial health beyond just this single metric.
How does PT Prodia Widyahusada Tbk's Forward PE Ratio compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, PT Prodia Widyahusada Tbk ranks #8 out of 87 companies for Forward PE Ratio. This places PT Prodia Widyahusada Tbk in the top 9% of its industry — outperforming the majority of peers. The industry median Forward PE Ratio is 21.92. PT Prodia Widyahusada Tbk's value of 11.54 is 47.4% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward PE Ratio for a Medical Diagnostics & Research company?
The median Forward PE Ratio among Medical Diagnostics & Research companies is 21.92, based on 87 companies in the industry. Companies in the top quartile (top 25%) have a Forward PE Ratio significantly above this median, while those in the bottom quartile fall well below. However, Forward PE Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PT Prodia Widyahusada Tbk's current Forward PE Ratio of 11.54 is 47.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward PE Ratio mean?
A high Forward PE Ratio can signal that a stock is expensive relative to its fundamentals. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on PT Prodia Widyahusada Tbk and its competitors. For the Medical Diagnostics & Research industry, the median Forward PE Ratio is 21.92 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Prodia Widyahusada Tbk's current Forward PE Ratio is 11.54. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Prodia Widyahusada Tbk stock overvalued right now?
PT Prodia Widyahusada Tbk (PRWDF) has a current Forward PE Ratio of 11.54. The current Forward PE Ratio is 11.54 and 47.4% below the Medical Diagnostics & Research industry median of 21.92. PT Prodia Widyahusada Tbk's overall GF Score™ is 76/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward PE Ratio calculated?
Forward PE Ratio is calculated from a company's financial statements. For PT Prodia Widyahusada Tbk (PRWDF), the current Forward PE Ratio is 11.54 as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
PT Prodia Widyahusada Tbk provides health care testing services. The company provides analytic and diagnostic services for the medical professionals. It is engaged in health laboratories by conducting business activities such as setting up clinics, health laboratories, management of hospitals, and health checkup services. Its operating segments are Central: Jakarta; Sumatera: Sumatera, Kepulauan Riau; Greater Jakarta: Jakarta, Bogor, Depok, Tangerang, Bekasi, Lampung, Pangkal Pinang; West Java; Central Java; East Java, Bali, Nusa Tenggara; Kalimantan Sulampua: Kalimantan, Sulawesi, Ambon, Papua.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PRWDF has been successfully added to your